Skip to main content
Clinical Trials/NCT05591313
NCT05591313
Completed
Not Applicable

Acute Exercise Effect on Neurocognitive Function Among Cognitively Normal Late-Middle-Aged Adults With/Without Generic Risk of Alzheimer's Disease: The Moderation Role of Exercise Volume and Apolipoprotein E Genotype

National Taiwan Normal University1 site in 1 country51 target enrollmentMay 17, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Alzheimer Disease 2 Due to Apoe4 Isoform
Sponsor
National Taiwan Normal University
Enrollment
51
Locations
1
Primary Endpoint
Stroop task: Accuracy
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

This study explores the acute exercise effect on neurocognitive function and also its potential moderators in an exercise setting and Apolipoprotein E (APOE) genetic risk.

Detailed Description

Acute exercise has emerged as a modifier to multiple aspects of cognitive function; however, its effect on populations with different risks of Alzheimer's disease (AD) and the role of exercise variance and APOE genotype within the effect reminds underestimated. The current study aimed to examine the acute exercise effect on neurocognitive function from behavioral and neuroelectric perspectives among cognitively normal late-middle-aged adults. Additionally, we determined whether variations in exercise intensity and duration and the presence of the APOE ɛ4 allele modulated the effect.

Registry
clinicaltrials.gov
Start Date
May 17, 2016
End Date
September 26, 2019
Last Updated
3 years ago
Study Type
Interventional
Study Design
Factorial
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Yu-Kai Chang

Proffessor

National Taiwan Normal University

Eligibility Criteria

Inclusion Criteria

  • Adults aged between 50 and 70 years old
  • Normal or corrected-to-normal vision based on the minimal 20/20 standard
  • Cognitively normal as mini-mental state examination scores (MMSE) \> 26

Exclusion Criteria

  • Neurological or psychiatric disorders
  • Cardiovascular disease
  • Risk of cardiovascular fitness assessment based on the Physical Activity Readiness Questionnaire (PAR-Q)
  • Red-green color blindness.

Outcomes

Primary Outcomes

Stroop task: Accuracy

Time Frame: Participants were required to complete the Stroop task approximately 30 min following the cessation of each acute exercise treatment or the 30-min reading.

A computerized Stroop task was used to assess participants' inhibitory control and basic information processing. The accuracy was calculated for the second behavioral index.

Event-related potential: P3 amplitude

Time Frame: Participants were required to complete the Stroop task while EEG activity was continuously recorded approximately 30 min following the cessation of each acute exercise treatment or the 30-min reading.

The event-related potential from parietal electrodes (i.e., P3, Pz, and P4) were initially outputted for the mean P3 amplitude; the averaged mean P3 amplitudes from parietal electrodes was then calculated as the neuroelectrical indices.

Stroop task: Response time

Time Frame: Participants were required to complete the Stroop task approximately 30 min following the cessation of each acute exercise treatment or the 30-min reading.

A computerized Stroop task was used to assess participants' inhibitory control and basic information processing. The response time of the correct responses was calculated for the first behavioral index.

Study Sites (1)

Loading locations...

Similar Trials